Total Payments
$7,654
2024 Payments
$1,452
Companies
36
Transactions
406
Medicare Patients
3,982
Medicare Billing
$201,914
Payment Breakdown by Category
Food & Beverage$7,598 (99.3%)
Education$55.49 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,598 | 401 | 99.3% |
| Education | $55.49 | 5 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,576 | 110 | $0 (2024) |
| Amgen Inc. | $938.08 | 62 | $0 (2024) |
| Medtronic Vascular, Inc. | $855.16 | 14 | $0 (2019) |
| PFIZER INC. | $374.45 | 22 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $342.99 | 21 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $342.70 | 14 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $340.11 | 21 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $297.27 | 21 | $0 (2022) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $265.48 | 16 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $219.84 | 15 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,452 | 79 | Novartis Pharmaceuticals Corporation ($434.68) |
| 2023 | $1,371 | 61 | Novartis Pharmaceuticals Corporation ($212.36) |
| 2022 | $510.58 | 30 | Amgen Inc. ($106.70) |
| 2021 | $512.68 | 27 | Novartis Pharmaceuticals Corporation ($141.82) |
| 2020 | $44.32 | 1 | PFIZER INC. ($44.32) |
| 2019 | $804.12 | 43 | Medtronic Vascular, Inc. ($246.18) |
| 2018 | $1,566 | 84 | Medtronic Vascular, Inc. ($327.82) |
| 2017 | $1,393 | 81 | Novartis Pharmaceuticals Corporation ($444.04) |
All Payment Transactions
406 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $6.81 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.86 | General |
| Category: Cardiovascular | ||||||
| 12/09/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/03/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/26/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/15/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Cardiology | ||||||
| 11/13/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.41 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/01/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $28.39 | General |
| Category: Genetic Disease | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/25/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: Cardiology | ||||||
| 10/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $24.02 | General |
| Category: Cardiovascular | ||||||
| 10/17/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $8.29 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $9.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/14/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $17.21 | General |
| Category: Cardiology | ||||||
| 10/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: DIABETES | ||||||
| 10/09/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/02/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.74 | General |
| Category: Cardiovascular | ||||||
| 09/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/24/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $4.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/17/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/04/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $29.89 | General |
| Category: Genetic Disease | ||||||
| 09/03/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $18.30 | General |
| Category: Cardiology | ||||||
| 08/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 997 | 1,248 | $173,555 | $47,758 |
| 2022 | 18 | 895 | 1,074 | $139,054 | $41,593 |
| 2021 | 16 | 1,004 | 1,253 | $194,076 | $59,122 |
| 2020 | 20 | 1,086 | 1,276 | $191,260 | $53,440 |
Total Patients
3,982
Total Services
4,851
Medicare Billing
$201,914
Procedure Codes
80
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 97 | 126 | $16,868 | $9,153 | 54.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 48 | 89 | $14,329 | $5,579 | 38.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 47 | 58 | $18,096 | $5,424 | 30.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 69 | 90 | $7,921 | $4,423 | 55.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 71 | 72 | $32,184 | $3,576 | 11.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 20 | 32 | $7,360 | $3,060 | 41.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 53 | 53 | $13,939 | $2,960 | 21.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 38 | 40 | $10,680 | $2,673 | 25.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 18 | 18 | $8,064 | $2,343 | 29.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 260 | 325 | $12,675 | $1,900 | 15.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $3,648 | $1,258 | 34.5% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Facility | 2023 | 19 | 61 | $3,599 | $1,233 | 34.3% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Facility | 2023 | 25 | 41 | $2,829 | $930.15 | 32.9% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 60 | 60 | $5,940 | $888.56 | 15.0% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 62 | 62 | $4,092 | $611.80 | 15.0% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Facility | 2023 | 16 | 20 | $1,980 | $583.40 | 29.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 40 | 47 | $3,572 | $494.08 | 13.8% |
| 93280 | Programming of dual lead pacemaker system | Facility | 2023 | 17 | 17 | $3,604 | $451.88 | 12.5% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 25 | 25 | $2,175 | $215.12 | 9.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 107 | 144 | $18,876 | $10,438 | 55.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 75 | 93 | $7,873 | $4,735 | 60.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 20 | 20 | $8,520 | $3,211 | 37.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 37 | 44 | $12,766 | $3,113 | 24.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 60 | 60 | $25,500 | $3,057 | 12.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 23 | 38 | $5,814 | $2,201 | 37.9% |
About Dr. Brian Cospolich, MD
Dr. Brian Cospolich, MD is a Cardiovascular Disease healthcare provider based in Marrero, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1326004920.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Cospolich, MD has received a total of $7,654 in payments from pharmaceutical and medical device companies, with $1,452 received in 2024. These payments were reported across 406 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($7,598).
As a Medicare-enrolled provider, Cospolich has provided services to 3,982 Medicare beneficiaries, totaling 4,851 services with total Medicare billing of $201,914. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Marrero, LA
- Active Since 04/22/2006
- Last Updated 07/09/2013
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1326004920
Products in Payments
- ENTRESTO (Drug) $1,185
- Repatha (Biological) $635.05
- ELIQUIS (Drug) $468.50
- LEQVIO (Drug) $390.91
- Corlanor (Drug) $299.03
- XARELTO (Drug) $297.27
- JARDIANCE (Drug) $296.44
- LifeVest (Device) $265.48
- Resolute (Device) $263.48
- Micra (Device) $236.62
- PRALUENT (Drug) $190.78
- ONPATTRO (Drug) $181.83
- BRILINTA (Drug) $176.22
- RESOLUTE ONYX (Device) $171.67
- Claria MRI (Device) $161.29
- NEXLETOL (Drug) $151.10
- Livalo (Drug) $141.02
- FARXIGA (Drug) $118.64
- Assure WCD (Device) $114.64
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) $114.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Marrero
Dr. Frederick Kushner, Md, MD
Cardiovascular Disease — Payments: $85,845
Cardiovascular Disease $85,845
Dr. Carlos Rodriguez Fierro, M.d, M.D
Cardiovascular Disease — Payments: $18,027
Cardiovascular Disease $18,027
Dr. Robert Matheney, Md, MD
Cardiovascular Disease — Payments: $12,679
Cardiovascular Disease $12,679
Dr. Leslie Levenson, Md, MD
Cardiovascular Disease — Payments: $10,003
Cardiovascular Disease $10,003
Dr. Edmund Kerut, Md, MD
Cardiovascular Disease — Payments: $8,615
Cardiovascular Disease $8,615
Stephen Laguardia, Md, MD
Cardiovascular Disease — Payments: $7,756
Cardiovascular Disease $7,756